Mysore S. Veena

2.4k total citations · 2 hit papers
28 papers, 1.9k citations indexed

About

Mysore S. Veena is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Mysore S. Veena has authored 28 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Mysore S. Veena's work include Curcumin's Biomedical Applications (6 papers), Retinoids in leukemia and cellular processes (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Mysore S. Veena is often cited by papers focused on Curcumin's Biomedical Applications (6 papers), Retinoids in leukemia and cellular processes (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Mysore S. Veena collaborates with scholars based in United States, Sweden and India. Mysore S. Veena's co-authors include Eri S. Srivatsan, Marilene B. Wang, Reason Wilken, Alen N. Cohen, Saroj K. Basak, Rita Chakrabarti, Kym F. Faull, Jeffrey D. Suh, Victor M. Duarte and Daniel Sanghoon Shin and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Mysore S. Veena

27 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma

2011 823 citations Reason Wilken, Mysore S. Veena et al. profile →
Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors

2025 20 citations Salma Khan, Yeonjoo Choi et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mysore S. Veena United States	19	944	848	327	308	187	28	1.9k
David P. Berry United Kingdom	17	942 1.0×	882 1.0×	170 0.5×	273 0.9×	289 1.5×	23	1.7k
Chengguang Zhao China	25	1.0k 1.1×	406 0.5×	281 0.9×	500 1.6×	170 0.9×	47	1.9k
Sita Aggarwal United States	16	834 0.9×	432 0.5×	233 0.7×	281 0.9×	115 0.6×	27	1.4k
Amit Deorukhkar United States	18	953 1.0×	300 0.4×	349 1.1×	263 0.9×	147 0.8×	34	1.8k
Christopher R. Ireson United Kingdom	14	1.7k 1.8×	1.4k 1.7×	210 0.6×	333 1.1×	403 2.2×	18	3.0k
Thambi Dorai United States	23	1.4k 1.5×	464 0.5×	284 0.9×	342 1.1×	146 0.8×	46	2.2k
Frederick Luk Australia	15	897 1.0×	306 0.4×	402 1.2×	371 1.2×	73 0.4×	16	1.5k
Monica Notarbartolo Italy	26	948 1.0×	326 0.4×	224 0.7×	389 1.3×	185 1.0×	66	1.7k
A.R.M. Ruhul Amin United States	28	1.6k 1.7×	318 0.4×	475 1.5×	608 2.0×	261 1.4×	62	3.0k
Bhaumik B. Patel United States	25	1.3k 1.3×	435 0.5×	469 1.4×	805 2.6×	119 0.6×	62	2.3k

Countries citing papers authored by Mysore S. Veena

Since Specialization

Citations

This map shows the geographic impact of Mysore S. Veena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mysore S. Veena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mysore S. Veena more than expected).

Fields of papers citing papers by Mysore S. Veena

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mysore S. Veena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mysore S. Veena. The network helps show where Mysore S. Veena may publish in the future.

Co-authorship network of co-authors of Mysore S. Veena

This figure shows the co-authorship network connecting the top 25 collaborators of Mysore S. Veena. A scholar is included among the top collaborators of Mysore S. Veena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mysore S. Veena. Mysore S. Veena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khan, Salma, Yeonjoo Choi, Mysore S. Veena, John K. Lee, & Daniel Sanghoon Shin. (2025). Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors. Frontiers in Immunology. 15. 1489827–1489827. 20 indexed citations breakdown →

Shin, Daniel Sanghoon, Saroj K. Basak, Mysore S. Veena, et al.. (2024). Enhanced CTLA‐4 blockade anti‐tumor immunity with APG‐157 combination in a murine head and neck cancer. Cancer Medicine. 13(9). e7212–e7212. 1 indexed citations

Veena, Mysore S., et al.. (2024). DRUG REVIEW OF YAVANI (TRACHYSPERMUM AMMI). International Ayurvedic Medical Journal. 12(1). 141–149.

Veena, Mysore S., et al.. (2023). Acidification of intracellular pH in MM tumor cells overcomes resistance to hypoxia-mediated apoptosis in vitro and in vivo. Frontiers in Oncology. 13. 1268421–1268421. 3 indexed citations

Veena, Mysore S., et al.. (2021). Can Targeting Hypoxia-Mediated Acidification of the Bone Marrow Microenvironment Kill Myeloma Tumor Cells?. Frontiers in Oncology. 11. 703878–703878. 9 indexed citations

Veena, Mysore S., Santanu Raychaudhuri, Saroj K. Basak, et al.. (2020). Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer. Journal of Biological Chemistry. 295(50). 17169–17186. 22 indexed citations

Veena, Mysore S., et al.. (2017). Restoration of the prolyl-hydroxylase domain protein-3 oxygen-sensing mechanism is responsible for regulation of HIF2α expression and induction of sensitivity of myeloma cells to hypoxia-mediated apoptosis. PLoS ONE. 12(12). e0188438–e0188438. 5 indexed citations

Veena, Mysore S., Reason Wilken, Junying Zheng, et al.. (2014). p16 Protein and Gigaxonin Are Associated with the Ubiquitination of NFκB in Cisplatin-induced Senescence of Cancer Cells. Journal of Biological Chemistry. 289(50). 34921–34937. 24 indexed citations

An, Jiabin, Huiren Liu, Clara E. Magyar, et al.. (2013). Hyperactivated JNK Is a Therapeutic Target in pVHL-Deficient Renal Cell Carcinoma. Cancer Research. 73(4). 1374–1385. 45 indexed citations

10.

Basak, Saroj K., Mysore S. Veena, Scott Oh, et al.. (2013). Correction: The CD44^highTumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a Expression. PLoS ONE. 8(9). 3 indexed citations

11.

Vira, Darshni, Saroj K. Basak, Mysore S. Veena, et al.. (2012). Cancer stem cells, microRNAs, and therapeutic strategies including natural products. Cancer and Metastasis Reviews. 31(3-4). 733–751. 47 indexed citations

12.

Veena, Mysore S., Saroj K. Basak, Eugene Han, et al.. (2011). Curcumin Treatment Suppresses IKKβ Kinase Activity of Salivary Cells of Patients with Head and Neck Cancer: A Pilot Study. Clinical Cancer Research. 17(18). 5953–5961. 96 indexed citations

13.

Duarte, Victor M., Eugene Han, Mysore S. Veena, et al.. (2010). Curcumin Enhances the Effect of Cisplatin in Suppression of Head and Neck Squamous Cell Carcinoma via Inhibition of IKKβ Protein of the NFκB Pathway. Molecular Cancer Therapeutics. 9(10). 2665–2675. 99 indexed citations

14.

Cohen, Alen N., Mysore S. Veena, Eri S. Srivatsan, & Marilene B. Wang. (2009). Suppression of Interleukin 6 and 8 Production in Head and Neck Cancer Cells With Curcumin via Inhibition of Iκβ Kinase. Archives of Otolaryngology - Head and Neck Surgery. 135(2). 190–190. 61 indexed citations

15.

Basak, Saroj K., Mysore S. Veena, Ge Huang, et al.. (2009). The Malignant Pleural Effusion as a Model to Investigate Intratumoral Heterogeneity in Lung Cancer. PLoS ONE. 4(6). e5884–e5884. 50 indexed citations

16.

Veena, Mysore S., Min Qin, Åsa Andersson, Sherven Sharma, & Raj K. Batra. (2009). CAR mediates efficient tumor engraftment of mesenchymal type lung cancer cells. Laboratory Investigation. 89(8). 875–886. 15 indexed citations

17.

An, Jiabin, Huiren Liu, Mysore S. Veena, et al.. (2008). Inactivation of the CYLD Deubiquitinase by HPV E6 Mediates Hypoxia-Induced NF-κB Activation. Cancer Cell. 14(5). 394–407. 86 indexed citations

18.

Veena, Mysore S., Grant Lee, Daniel Keppler, et al.. (2008). Inactivation of the cystatin E/M tumor suppressor gene in cervical cancer. Genes Chromosomes and Cancer. 47(9). 740–754. 29 indexed citations

19.

Yip, Helena T., Rajesh Chopra, Rita Chakrabarti, et al.. (2006). Cisplatin-Induced Growth Arrest of Head and Neck Cancer Cells Correlates With Increased Expression of p16 and p53. Archives of Otolaryngology - Head and Neck Surgery. 132(3). 317–317. 30 indexed citations

20.

Zainabadi, Kayvan, Rita Chakrabarti, Mysore S. Veena, et al.. (2005). A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13. Genomics. 85(6). 704–714. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact